Points to Consider No. 15: Mobile Manufacturing

NEW
Published
Nov 2025
ISBN
978-1-945584-56-5
Pages
22
PDA Item Number
43597
Format
PDF Single User
Member Price
$180.00
Nonmember Price
$325.00
Government Price
$180.00

**Premium members: Download your free copy by 12/20/2025!**

This Points to Consider document aims to assess the feasibility and requirements for designing and qualifying a self-contained manufacturing process that, once validated, can be relocated and operated in a different location for the same process, without the requirement for regulatory preapproval or revalidation.The document includes exploring the technology supporting mobile manufacturing in greater detail and the regulatory requirements and risks associated with moving a manufacturing process from one location to another. While mobile manufacturing can be considered an enabling technology for distributed manufacturing or point-of-care manufacturing, the scope of this paper excludes identifying or elaborating on those requirements.

Table of Contents

  • Topic 1. Technology Considerations
  • Topic 2. Regulatory Considerations
  • Topic 3. Implementation
  • Appendix A: Regulatory Compliance Expectations
  • References

About the Authors

  • Pete Makowenskyj, G-CON Manufacturing (Co-Lead)
  • Niraj Mehta, Lupin Pharmaceuticals (Co-Lead)
  • Jotti Bajwa, Genentech
  • Kurt Brorson, Parexel
  • Veronique Davoust, Pfizer
  • Karolyn Gale, Emergent BioSolutions
  • John Lewin, On Demand Pharmaceuticals
  • Riley Myers, NIIMBL (Ex-FDA)
  • Siegfried Schmitt, Parexel